食管鳞状细胞癌中肿瘤抑制基因的启动子甲基化
Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.
作者信息
Li Ji-Sheng, Ying Jian-Ming, Wang Xiu-Wen, Wang Zhao-Hui, Tao Qian, Li Li-Li
机构信息
Department of Chemotherapy, Shandong University, Jinan, Shandong, People's Republic of China.
出版信息
Chin J Cancer. 2013 Jan;32(1):3-11. doi: 10.5732/cjc.011.10381. Epub 2012 May 8.
Abstract
Esophageal squamous cell carcinoma (ESCC) is a prevalent and fatal cancer in China and other Asian countries. Epigenetic silencing of key tumor suppressor genes (TSGs) is critical to ESCC initiation and progression. Recently, many novel TSGs silenced by promoter methylation have been identified in ESCC, and these genes further serve as potential tumor markers for high-risk group stratification, early detection, and prognosis prediction. This review summarizes recent discoveries on aberrant promoter methylation of TSGs in ESCC, providing better understanding of the role of disrupted epigenetic regulation in tumorigenesis and insight into diagnostic and prognostic biomarkers for this malignancy.
摘要
食管鳞状细胞癌（ESCC）在中国和其他亚洲国家是一种常见且致命的癌症。关键肿瘤抑制基因（TSG）的表观遗传沉默对ESCC的发生和发展至关重要。最近，在ESCC中已鉴定出许多因启动子甲基化而沉默的新型TSG，这些基因进一步可作为高危人群分层、早期检测和预后预测的潜在肿瘤标志物。本综述总结了ESCC中TSG启动子异常甲基化的最新发现，有助于更好地理解表观遗传调控紊乱在肿瘤发生中的作用，并为这种恶性肿瘤的诊断和预后生物标志物提供见解。
相似文献
1
Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.
Chin J Cancer. 2013 Jan;32(1):3-11. doi: 10.5732/cjc.011.10381. Epub 2012 May 8.
2
Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Oncogene. 2007 Sep 27;26(44):6456-68. doi: 10.1038/sj.onc.1210459. Epub 2007 Apr 16.
3
Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Int J Med Sci. 2014 May 30;11(8):779-87. doi: 10.7150/ijms.7405. eCollection 2014.
4
PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.
Dis Esophagus. 2014 May-Jun;27(4):396-402. doi: 10.1111/dote.12106. Epub 2013 Aug 27.
5
Aberrant promoter CpG methylation and its translational applications in breast cancer.
Chin J Cancer. 2013 Jan;32(1):12-20. doi: 10.5732/cjc.011.10344. Epub 2011 Nov 4.
6
Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
Bioinformatics. 2014 Nov 1;30(21):3054-61. doi: 10.1093/bioinformatics/btu433. Epub 2014 Jul 10.
7
HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.
8
Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
Dig Dis Sci. 2011 Mar;56(3):681-8. doi: 10.1007/s10620-010-1369-0. Epub 2010 Aug 20.
9
The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
Clin Epigenetics. 2016 Apr 22;8:43. doi: 10.1186/s13148-016-0210-9. eCollection 2016.
10
Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Tumour Biol. 2016 Apr;37(4):5621-32. doi: 10.1007/s13277-015-4432-9. Epub 2015 Nov 17.
引用本文的文献
1
DNA methylation in esophageal cancer: technological advances and early detection clinical applications.
Front Oncol. 2025 Jul 11;15:1543190. doi: 10.3389/fonc.2025.1543190. eCollection 2025.
2
Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma and its Clinical Implications in Systemic Chemotherapy.
Int J Med Sci. 2025 Feb 3;22(4):1002-1014. doi: 10.7150/ijms.109161. eCollection 2025.
3
Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells.
Oncogene. 2022 Sep;41(40):4537-4546. doi: 10.1038/s41388-022-02366-y. Epub 2022 Sep 5.
4
DNA methylation markers in esophageal cancer: an emerging tool for cancer surveillance and treatment.
Am J Cancer Res. 2021 Nov 15;11(11):5644-5658. eCollection 2021.
5
Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma.
MedComm (2020). 2021 Jan 7;2(2):175-206. doi: 10.1002/mco2.32. eCollection 2021 Jun.
6
Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.
Front Oncol. 2020 Oct 23;10:549850. doi: 10.3389/fonc.2020.549850. eCollection 2020.
7
Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2.
Int J Biol Sci. 2020 Sep 16;16(15):2938-2950. doi: 10.7150/ijbs.47051. eCollection 2020.
8
Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma.
J Cell Mol Med. 2020 Sep;24(18):10551-10559. doi: 10.1111/jcmm.15673. Epub 2020 Jul 30.
9
Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer.
J Biomed Res. 2018 Nov 20;32(5):424-433. doi: 10.7555/JBR.32.20170065.
10
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.
Medicine (Baltimore). 2018 Aug;97(31):e11697. doi: 10.1097/MD.0000000000011697.
本文引用的文献
1
The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas.
Oncogene. 2012 Aug 23;31(34):3901-12. doi: 10.1038/onc.2011.541. Epub 2011 Dec 5.
2
MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor.
Gut. 2012 Jan;61(1):33-42. doi: 10.1136/gutjnl-2011-300178. Epub 2011 Aug 3.
3
Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
Dig Dis Sci. 2011 Nov;56(11):3195-203. doi: 10.1007/s10620-011-1734-7. Epub 2011 May 13.
4
CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
Int J Cancer. 2012 Apr 1;130(7):1607-13. doi: 10.1002/ijc.26171. Epub 2011 Aug 24.
5
Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
J Recept Signal Transduct Res. 2011 Apr;31(2):147-56. doi: 10.3109/10799893.2011.553836.
6
Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma.
BMC Cancer. 2011 Mar 5;11:91. doi: 10.1186/1471-2407-11-91.
7
Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Int J Mol Med. 2011 May;27(5):625-35. doi: 10.3892/ijmm.2011.640. Epub 2011 Mar 3.
8
Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
J Thorac Cardiovasc Surg. 2011 Mar;141(3):808-14. doi: 10.1016/j.jtcvs.2010.04.031.
9
Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma.
Int J Oncol. 2011 Apr;38(4):1129-35. doi: 10.3892/ijo.2011.918. Epub 2011 Jan 21.
10
Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma.
Epigenetics. 2011 Mar;6(3):307-16. doi: 10.4161/epi.6.3.14182. Epub 2011 Mar 1.
Zotero 插件